Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine

NCT04508075 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1620

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV2 Infection

Interventions

BIOLOGICAL: SARS-CoV-2 vaccine (inactivated)
BIOLOGICAL: Placebo

Sponsor

PT Bio Farma

Collaborators

[object Object]
[object Object]
[object Object]